Alliancebernstein L.P. Global Blood Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$32.4 - $68.18 $10.6 Million - $22.3 Million	326,790 Added 450.74%	399,290 $27.2 Million
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $17,795 - $29,837	798 Added 1.11%	72,500 $2.32 Million
Q1 2022 May 13, 2022	BUY	$25.68 - $35.59 $5,136 - $7,118	200 Added 0.28%	71,702 $2.48 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $27,390 - $44,286	-1,100 Reduced 1.52%	71,502 $2.09 Million
Q2 2021 Jul 30, 2021	BUY	$32.46 - $43.42 $1.47 Million - $1.97 Million	45,267 Added 165.6%	72,602 $2.54 Million
Q1 2021 May 06, 2021	SELL	$38.94 - $50.85 $401,159 - $523,856	-10,302 Reduced 27.37%	27,335 $1.11 Million
Q4 2020 Feb 08, 2021	SELL	$37.65 - $63.77 $5,798 - $9,820	-154 Reduced 0.41%	37,637 $1.63 Million
Q3 2020 Nov 12, 2020	SELL	$52.76 - $74.49 $337,294 - $476,214	-6,393 Reduced 14.47%	37,791 $2.08 Million
Q2 2020 Aug 13, 2020	SELL	$48.73 - $81.82 $4.08 Million - $6.85 Million	-83,716 Reduced 65.45%	44,184 $2.79 Million
Q1 2020 May 14, 2020	BUY	$41.72 - $87.2 $45,892 - $95,920	1,100 Added 0.87%	127,900 $6.53 Million
Q4 2019 Feb 18, 2020	BUY	$45.7 - $81.86 $2.07 Million - $3.71 Million	45,300 Added 55.58%	126,800 $10.1 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $383,980 - $462,017	7,300 Added 9.84%	81,500 $4.29 Million
Q1 2019 May 14, 2019	BUY	$39.99 - $53.48 $35,991 - $48,132	900 Added 1.23%	74,200 $3.93 Million
Q3 2018 Nov 08, 2018	BUY	$38.0 - $51.1 $34,200 - $45,990	900 Added 1.24%	73,300 $2.79 Million
Q2 2018 Aug 13, 2018	BUY	$38.7 - $50.15 $654,030 - $847,535	16,900 Added 30.45%	72,400 $3.27 Million
Q1 2018 May 14, 2018	BUY	$39.6 - $65.9 $11,880 - $19,770	300 Added 0.54%	55,500 $2.68 Million
Q4 2017 Feb 13, 2018	SELL	$29.7 - $45.7 $594,000 - $914,000	-20,000 Reduced 26.6%	55,200 $2.17 Million
Q3 2017 Nov 13, 2017	BUY	$25.1 - $31.05 $1.89 Million - $2.33 Million	75,200	75,200 $2.34 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account